Patheon completes $2.65 billion merger with DSM | Pharmafile

Patheon completes $2.65 billion merger with DSM | Pharmafile:

"The amalgamation of the two contract development and manufacturing organisations (CDMOs) was first announced last November, when Patheon and its softgel capsule specialist Banner Pharmacaps combined with DSM’s pharma chemicals and contract manufacturing divisions to create a pharma outsourcing powerhouse.

DPx is now thought to be the second largest CDMO in the marketplace behind Catalent with around $2 billion in combined annual sales, and is 51% owned by Patheon’s private equity owner JLL Partners and 49% owned by DSM International. The combined company is headed by Jim Mullen, who was chief executive of Patheon."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store